1 | Report | 1.7% | |
2 | Cancer | 1.42% | |
3 | Case | 1.42% | |
4 | Disease | 1.42% | |
5 | Treatment | 1.14% | |
6 | Review | 0.85% | |
7 | Renal | 0.85% | |
8 | Therapy | 0.85% | |
9 | Carcinoma | 0.85% | |
10 | Rare | 0.85% | |
11 | According | 0.85% | |
12 | Cell | 0.85% | |
13 | ASCO | 0.85% | |
14 | Paciente | 0.57% | |
15 | New | 0.57% | |
16 | Health | 0.57% | |
17 | Wegovy | 0.57% | |
18 | Clinical | 0.57% | |
19 | Was | 0.57% | |
20 | PA | 0.57% | |
21 | Ozempic | 0.57% | |
22 | Combo | 0.57% | |
23 | Loss | 0.57% | |
24 | May | 0.57% | |
25 | Weight | 0.57% | |
26 | Bone | 0.57% | |
27 | Bilateral | 0.57% | |
28 | This | 0.57% | |
29 | Por | 0.57% | |
30 | Potential | 0.57% | |
31 | Trial | 0.57% | |
32 | Boosts | 0.28% | |
33 | Drinks | 0.28% | |
34 | Gut-Associated | 0.28% | |
35 | Bad | 0.28% | |
36 | Influenza | 0.28% | |
37 | Beyond | 0.28% | |
38 | Gut | 0.28% | |
39 | Mounjaro | 0.28% | |
40 | Reconstruction | 0.28% | |
41 | Gain | 0.28% | |
42 | Covid-19 | 0.28% | |
43 | Reveals | 0.28% | |
44 | ccRCC | 0.28% | |
45 | Junin | 0.28% | |
46 | Effectiveness | 0.28% | |
47 | Cause | 0.28% | |
48 | Lip | 0.28% | |
49 | DEL | 0.28% | |
50 | Day | 0.28% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
From Resistance to Response: The Microbiome’s Role in Optimizing Cancer Therapy
Pharmacy Times
2025-06-01 07:58:55